$211.17
arrow_drop_down7.15%Key Stats | |
---|---|
Open | $210.83 |
Prev. Close | $227.44 |
EPS | 7.99 |
Dividend | Non-Dividend |
Next Earnings Date | - |
Dividend Yield % | - |
LOW | HIGH | |
---|---|---|
Day Range | 210.00 | 217.53 |
52 Week Range | 189.44 | 278.95 |
Ratios | |
---|---|
EPS | 7.99 |
Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.
Period: Next 12 Months
•Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.
BIIB DEADLINE ALERT: Kessler Topaz Meltzer & Check, LLP - GlobeNewswire
Mizuho cuts Sage Therapeutics stock target By Investing.com - Investing.com Australia
INVESTOR DEADLINE NEXT WEEK: Robbins Geller Rudman & Dowd - GlobeNewswire
Bernie Sanders: 'Getting Sick In America Should Not Mean Going Bankrupt, Losing Your Home, Car, Or Life Savings' - Benzinga
BIIB Deadline Alert: Kessler Topaz Meltzer & Check, LLP - GlobeNewswire
Is Eli Lilly a Good Dividend Stock to Buy Now? - The Motley Fool
Join our exclusive community of over one million investment enthusiasts and receive our free newsletter filled with analysis, news, and updates every weekday.